Pharmaceuticals 2010, 3(10), 3343-3354; doi:10.3390/ph3103343
Review

Anti-Viral Drugs for Human Adenoviruses

* email and
Received: 2 September 2010; in revised form: 23 October 2010 / Accepted: 25 October 2010 / Published: 25 October 2010
(This article belongs to the Special Issue Antivirals)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: There are many stages in the development of a new drug for viral infection and such processes are even further complicated for adenovirus by the fact that there are at least 51 serotypes, forming six distinct groups (A–F), with different degree of infectivity. This review attempts to address the importance of developing pharmaceuticals for adenovirus and also review recent development in drug discovery for adenovirus, including newer strategies such as microRNA approaches. Different drug screening strategies will also be discussed.
Keywords: adenovirus; pharmaceuticals; microRNA
PDF Full-text Download PDF Full-Text [607 KB, uploaded 25 October 2010 14:53 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Waye, M.M.Y.; Sing, C.W. Anti-Viral Drugs for Human Adenoviruses. Pharmaceuticals 2010, 3, 3343-3354.

AMA Style

Waye MMY, Sing CW. Anti-Viral Drugs for Human Adenoviruses. Pharmaceuticals. 2010; 3(10):3343-3354.

Chicago/Turabian Style

Waye, Mary Miu Yee; Sing, Chor Wing. 2010. "Anti-Viral Drugs for Human Adenoviruses." Pharmaceuticals 3, no. 10: 3343-3354.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert